Skip to main content
Genus plc (LON:GNS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
2,645.00
-25.00 (-0.94%)
Mar 9, 2026, 4:47 PM GMT

Genus Revenue

Genus had revenue of 335.60M GBP in the half year ending December 31, 2025, with 0.60% growth. This brings the company's revenue in the last twelve months to 672.00M, up 0.06% year-over-year. In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M with 0.60% growth.

Revenue (ttm)
672.00M
Revenue Growth
+0.06%
P/S Ratio
2.66
Revenue / Employee
210.66K
Employees
3,190
Market Cap
1.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025672.80M4.00M0.60%
Jun 30, 2024668.80M-20.90M-3.03%
Jun 30, 2023689.70M96.30M16.23%
Jun 30, 2022593.40M19.10M3.33%
Jun 30, 2021574.30M22.90M4.15%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oxford Nanopore Technologies 223.90M
Oxford Biomedica 151.21M
Avacta Group 113.00K
PureTech Health 4.66M
Scancell Holdings 4.71M
4basebio 1.78M
Bioventix 13.12M
Faron Pharmaceuticals Oy 1.14M
Revenue Rankings

Genus News

More News